IFP Advisors’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
– Sell
-1,203
Closed -$403K – 3475
2024
Q2
$403K Sell
1,203
-6
-0.5% -$1.98K 0.02% 729
2024
Q1
$394K Sell
1,209
-5
-0.4% -$1.23K 0.02% 692
2023
Q4
$231K Sell
1,214
-6
-0.5% -$1.13K 0.01% 885
2023
Q3
$243K Sell
1,220
-536
-31% -$127K 0.01% 881
2023
Q2
$501K Buy
1,756
+469
+36% +$130K 0.02% 655
2023
Q1
$39.3K Sell
1,287
-535
-29% -$104K ﹤0.01% 1694
2022
Q4
$75K Buy
1,822
+286
+19% +$72.3K ﹤0.01% 1952
2022
Q3
$64K Buy
1,536
+201
+15% +$51.1K ﹤0.01% 2192
2022
Q2
$48K Hold
1,335
– – ﹤0.01% 2202
2022
Q1
$48K Buy
1,335
+181
+16% +$29.8K ﹤0.01% 2202
2021
Q4
$206K Buy
1,154
+3
+0.3% +$592 ﹤0.01% 936
2021
Q3
$237K Sell
1,151
-39
-3% -$7.66K ﹤0.01% 877
2021
Q2
$224K Sell
1,190
-5
-0.4% -$818 ﹤0.01% 852
2021
Q1
$157K Buy
1,195
+135
+13% +$16.2K ﹤0.01% 953
2020
Q4
$109K Buy
1,060
+1,035
+4,140% +$89.6K ﹤0.01% 1092
2020
Q3
$2K Hold
25
– – ﹤0.01% 2538
2020
Q2
$1K Buy
+25
New +$1.03K ﹤0.01% 2645

Other funds holding SWAV

IFP Advisors's SWAV Position: Q3 2024 in Review

IFP Advisors sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q3 2024, closing a stake of 1,203 shares — an estimated $403K sold.

IFP Advisors first reported a position in SWAV in Q2 2020 and held it in 17 quarters. The position peaked at $501K in Q2 2023. 2 funds tracked by Wall St. Rank hold SWAV as of Q3 2024.

  • IFP Advisors reported no remaining Shockwave Medical, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • IFP Advisors sold 1,203 Shockwave Medical, Inc. Common Stock shares in Q3 2024, an estimated $403K.
  • IFP Advisors first reported a position in Shockwave Medical, Inc. Common Stock in Q2 2020 and held it in 17 quarters.
  • IFP Advisors's Shockwave Medical, Inc. Common Stock position peaked at $501K in Q2 2023.
  • 2 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q3 2024.

Based on IFP Advisors's 13F filing for Q3 2024, filed 4 Feb 2025.